Geri
Hansoh Pharmaceutical Group Company Limited (3692.HK) Fiyatı
3692.HK Hisse Senedi Fiyat Grafiği
HANSOH PHARMA (3692.HK)
Hansoh Pharmaceutical Group Company Limited
HK$41.28
-2.91%
$-1.24
Piyasa Kapalı: Jan 19, 16:00:00 HKT
Earnings FAQ
3692.HK'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Hansoh Pharmaceutical Group Company Limited 3692.HK'ün son çeyrekteki geliri nasıl performans gösterdi?
Hansoh Pharmaceutical Group Company Limited'in gelir tahmini nedir?
Hansoh Pharmaceutical Group Company Limited'in kazanç kalite puanı nedir?
Hansoh Pharmaceutical Group Company Limited kazançlarını ne zaman rapor eder?
Hansoh Pharmaceutical Group Company Limited'in beklenen kazançları nelerdir?
Hansoh Pharmaceutical Group Company Limited kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
$43
Açılış fiyatı
$42.52
Günün Aralığı
$40.74 - $43.42
52 haftalık aralık
$16.7 - $44.22
İşlem hacmi
5.9M
Ort.Hacim
8.3M
EPS (TTM)
0.89
Dividend yield
--
Piyasa Değeri
$245.4B
HANSOH PHARMA nedir?
Hansoh Pharmaceutical Group Co., Ltd. is a holding company, which engages in the research and development, production, and sale of a series of pharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 9,313 full-time employees. The company went IPO on 2019-06-14. The Company’s innovative drug products include Ameile, Hansoh Xinfu, Mailingda, Fulaimei, Hengmu, XINYUE, Saint Luolai and other products. The Company’s drug products are mainly used in oncology, anti-infective diseases, central nervous system (CNS) diseases, metabolic diseases and other therapeutic areas. The firm mainly conducts its business in the domestic market.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved